JSE set for second day of gains on virus treatment news

The JSE was on track for its second day of gains on Monday as developments in the search for a coronavirus treatment boosted risk appetite. 

Global equities rallied on news that the US Food and Drug Administration authorised the use of blood plasma as a treatment for Covid-19 patients. 

Source: businesslive.co.za